Walter J. Storkus
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Cell Biology, Microbiology BiologyGoogle:
"Walter Storkus"Children
Sign in to add traineeChristopher J. Herrem | grad student | 2004 | University of Pittsburgh |
Aklile Berhanu | grad student | 2005 | University of Pittsburgh |
Lazar N. Vujanovic | grad student | 2006 | University of Pittsburgh |
Mayumi Kawabe | grad student | 2009 | University of Pittsburgh |
Angela D. Pardee | grad student | 2010 | University of Pittsburgh |
Aparna Rao | grad student | 2012 | University of Pittsburgh |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Filderman JN, Taylor JL, Wang J, et al. (2024) Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonists. Frontiers in Immunology. 15: 1334769 |
Dong B, Obermajer N, Tsuji T, et al. (2023) NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8 T Cells. Research Square |
Vats K, Kruglov O, Sahoo B, et al. (2022) Sensory nerves impede the formation of tertiary lymphoid structures and development of protective anti-melanoma immune responses. Cancer Immunology Research |
Filderman JN, Storkus WJ. (2022) Finding the right help in the tumor microenvironment. The Journal of Clinical Investigation. 132 |
Saad M, Lee SJ, Tan AC, et al. (2022) Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males. Journal of Translational Medicine. 20: 253 |
Dai E, Zhu Z, Wahed S, et al. (2021) Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. Molecular Cancer. 20: 171 |
Storkus WJ, Maurer D, Lin Y, et al. (2021) Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma. Journal For Immunotherapy of Cancer. 9 |
Pontrelli P, Gigante M, Spadaccino F, et al. (2021) CD40 Cross-Linking Induces Migration of Renal Tumor Cell through Nuclear Factor of Activated T Cells (NFAT) Activation. International Journal of Molecular Sciences. 22 |
Amouzegar A, Chelvanambi M, Filderman JN, et al. (2021) STING Agonists as Cancer Therapeutics. Cancers. 13 |
Filderman JN, Appleman M, Chelvanambi M, et al. (2021) STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development. Frontiers in Immunology. 12: 690105 |